Prospective G7 Dual Mobility Total Hip PMCF
Public ClinicalTrials.gov record NCT03308929. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prospective Multi-Center Clinical Evaluation Following Total Hip Arthroplasty With the G7 Dual Mobility System
Study identification
- NCT ID
- NCT03308929
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Zimmer Biomet
- Industry
- Enrollment
- 250 participants
Conditions and interventions
Interventions
- G7 Dual Mobility hip Device
Device
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 27, 2017
- Primary completion
- Jun 30, 2027
- Completion
- Feb 27, 2029
- Last update posted
- Jun 14, 2025
2017 – 2029
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Jersey City Medical Center | Jersey City | New Jersey | 07302 | — |
| New Mexico Orthopaedics | Albuquerque | New Mexico | 87106 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27599 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Tidewater Orthopaedics | Hampton | Virginia | 23666 | — |
| Ortho Virginia | Richmond | Virginia | 23235 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03308929, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 14, 2025 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03308929 live on ClinicalTrials.gov.